Davis Capital Management’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Davis Capital Management's LMAT Position: Q3 2026 in Review
Davis Capital Management sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 1 share — an estimated $96 sold.
Davis Capital Management first reported a position in LMAT in Q2 2026 and held it in 1 quarter. The position peaked at $96 in Q2 2026. 238 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Davis Capital Management reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
- Davis Capital Management sold 1 LeMaitre Vascular share in Q3 2026, an estimated $96.
- Davis Capital Management first reported a position in LeMaitre Vascular in Q2 2026 and held it in 1 quarter.
- Davis Capital Management's LeMaitre Vascular position peaked at $96 in Q2 2026.
- 238 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.